RXRA and colorectal carcinoma: We showed that CCDC68 downregulation promoted the growth of CRC cells through the RXRα/ITCH/CDK4 axis, thereby identifying a new mechanism underlying the development of CRC and providing a theoretical basis for targeted therapy for CRC.